Financial Instruments

9 Months Ended

Mar. 31, 2026

Fair Value Disclosures [Abstract]

Financial Instruments

Financial instruments

The Company utilizes derivative and non-derivative financial instruments, including forward exchange contracts, cross-currency swap contracts and certain foreign currency denominated debt, to manage foreign currency transaction and translation risk. The derivative financial instrument contracts are with major investment grade financial institutions, and the Company does not anticipate any material non-performance by any of the counterparties. The Company does not hold or issue derivative financial instruments for trading purposes.

Net Investment Hedges

The Company uses cross-currency swap contracts and foreign currency denominated debt, a non-derivative financial instrument, to hedge portions of the Company's investments in foreign subsidiaries and manage foreign exchange risk. The effect of translating the debt into U.S. dollars is recorded in foreign currency translation within accumulated other comprehensive loss and remains there until the underlying net investment is sold or substantially liquidated. For the cross-currency swap contracts that are designated as, and qualify as, net investment hedges, we assess the effectiveness using the spot method and the net gains or losses attributable to changes in the spot rate are recorded in foreign currency translation within accumulated other comprehensive loss. Any ineffective portions of the net investment hedges are reclassified from accumulated other comprehensive loss into earnings through interest expense during the period of change. During the nine months ended March 31, 2026 and 2025, the periodic interest settlements related to the cross-currency swaps were not material.

The notional amounts for the cross-currency swap contracts designated as hedging instruments were €69 million, €290 million and ¥2.1 billion as of March 31, 2026 and June 30, 2025, respectively.

The Company’s €700 million aggregate principal amount of 2.90 percent Senior Notes due 2030 have been designated as a hedge of the Company’s net investment in certain foreign subsidiaries.

Non-Designated Derivative Contracts

In addition to the net investment hedges, the Company utilizes forward exchange contracts that are not designated as hedging instruments but serve as economic hedges of forecasted transactions. These derivatives are used to mitigate foreign exchange risk. Changes in the fair value of these instruments are recorded in other expense (income), net in the Consolidated Statements of Income.

Financial Statement Impact

Derivative financial instruments are recognized on the Consolidated Balance Sheets as either assets or liabilities and are measured at fair value. The location and fair value of derivative financial instruments reported on the Consolidated Balance Sheets are as follows:

	Balance Sheet Caption	March 31, 2026		June 30, 2025
Net investment hedges
Cross-currency swap contracts	Other long-term assets	$	6	$	4
Cross-currency swap contracts	Other long-term liabilities	8		26
Non-designated derivative contracts
Forward exchange contracts	Non-trade and notes receivable	24		3
Forward exchange contracts	Other current liabilities	6		38

The cross-currency swap and forward exchange contracts are reflected on a gross basis in the Consolidated Balance Sheets. The Company has not entered into any master netting arrangements.

Gains (losses) on derivative financial instruments were recorded in the Consolidated Statements of Income as follows:

	Three Months Ended				Nine Months Ended
	March 31,				March 31,
	2026		2025		2026		2025
Forward exchange contracts	$	35	$	(31)	$	56	$	(5)

Gains (losses) on derivative and non-derivative financial instruments that were recorded in accumulated other comprehensive loss in the Consolidated Balance Sheets are as follows:

	Three Months Ended				Nine Months Ended
	March 31,				March 31,
	2026		2025		2026		2025
Cross-currency swap contracts	$	10	$	4	$	15	$	2
Foreign currency denominated debt	12		(24)		12		(5)

Fair Values of Financial Instruments

The Company’s financial instruments include cash and cash equivalents, accounts receivable, accounts payable, notes payable and long-term debt. The carrying values for cash and cash equivalents, accounts receivable, accounts payable and notes payable approximate fair value due to their short-term nature.

The carrying value of long-term debt, including the current portion and excluding the impact of net unamortized debt issuance costs, and the estimated fair value are as follows:

	March 31, 2026		June 30, 2025
Carrying value of long-term debt	$	7,523	$	7,555
Estimated fair value of long-term debt	7,120		7,174

The fair value of long-term debt is classified within level 2 of the fair value hierarchy.

A summary of derivative assets and liabilities that were measured at fair value on a recurring basis at March 31, 2026 and June 30, 2025 is as follows:

	March 31, 2026		Level 1		Level 2		Level 3
Derivative assets	$	30	$	—	$	30	$	—
Derivative liabilities	14		—		14		—

	June 30, 2025		Level 1		Level 2		Level 3
Derivative assets	$	7	$	—	$	7	$	—
Derivative liabilities	64		—		64		—

The calculation of fair value for cross-currency swaps and forward contracts utilizes market observable inputs including both spot and forward prices for the same underlying currencies. The calculation of fair value of the cross-currency swap contracts also utilizes a present value cash flow model.